Issued Patents All Time
Showing 26–46 of 46 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11066363 | Substituted 6,11-dihydro-5H-benzo[B]carbazoles as inhibitors of ALK and SRPK | John Hatcher, Nathanael S. Gray, Hwangeun Choi, Pasi Janne | 2021-07-20 |
| 11040957 | Heteroaromatic compounds useful for the treatment of proliferative diseases | Stephane Ciblat, Patrick Deroy, Nathanael S. Gray, Melissa Leblanc, Jason J. Marineau +10 more | 2021-06-22 |
| 10981903 | Inhibitors of c-Jun-N-terminal kinase (JNK) | Nathanael S. Gray | 2021-04-20 |
| 10975055 | Inhibitors of interleukin-1 receptor-associated kinases and uses thereof | Nathanael S. Gray, John Hatcher, Sara Jean Buhrlage | 2021-04-13 |
| 10906889 | Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) | Nathanael S. Gray, Stephane Ciblat, Melissa Leblanc, Jason J. Marineau, Joel D. Moore +8 more | 2021-02-02 |
| 10875844 | Salicylate inhibitors of MELK and methods of use | Nathanael S. Gray, Hai-Tsang Huang, Yubao Wang, Jean Zhao, Hwan Geun Choi | 2020-12-29 |
| 10870651 | Inhibitors of cyclin-dependent kinase 7 (CDK7) | Nathanael S. Gray, Yanke Liang, Nicholas Paul Kwiatkowski | 2020-12-22 |
| 10865204 | Degradation of cyclin-dependent kinase 4/6 (CDK4/6) by conjugation of CDK4/6 inhibitors with E3 ligase ligand and methods of use | Nathanael S. Gray, Calla M. Olson, Yanke Liang, Nicholas Paul Kwiatkowski, Baishan Jiang +1 more | 2020-12-15 |
| 10865205 | Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use | Nathanael S. Gray, Calla M. Olson, Yanke Liang, Nicholas Paul Kwiatkowski | 2020-12-15 |
| 10787436 | Inhibitors of cyclin-dependent kinase 7 (CDK7) | Nathanael S. Gray, Nicholas Paul Kwiatkowski | 2020-09-29 |
| 10781207 | Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereof | Jianwei Che | 2020-09-22 |
| 10695346 | 4,6-pyrimidinylene derivatives and uses thereof | Nathanael S. Gray | 2020-06-30 |
| 10550121 | Inhibitors of cyclin-dependent kinases | Nathanael S. Gray, Nicholas Paul Kwiatkowski | 2020-02-04 |
| 10544138 | Tricyclic kinase inhibitors of MELK and methods of use | Nathanael S. Gray, Hai-Tsang Huang, Yubao Wang, Jean Zhao, Hwan Geun Choi | 2020-01-28 |
| 10532103 | Degradation of cyclin-dependent kinase 9 (CDK9) by conjugation of CDK9 inhibitors with E3 ligase ligand and methods of use | Nathanael S. Gray, Calla M. Olson, Yanke Liang, Nicholas Paul Kwiatkowski | 2020-01-14 |
| 10508082 | Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK | John Hatcher, Nathanael S. Gray, Hwan Geun Choi, Pasi Janne | 2019-12-17 |
| 10342798 | Fused bicyclic pyrimidine derivatives and uses thereof | Nathanael S. Gray | 2019-07-09 |
| 10144730 | Inhibitors of c-Jun-N-terminal kinase (JNK) | Nathanael S. Gray | 2018-12-04 |
| 10112927 | Inhibitors of cyclin-dependent kinase 7 (CDK7) | Nathanael S. Gray, Nicholas Paul Kwiatkowski | 2018-10-30 |
| 10047070 | Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) | Nathanael S. Gray, Stephane Ciblat, Melissa Leblanc, Jason J. Marineau, Joel D. Moore +8 more | 2018-08-14 |
| 9382239 | Inhibitors of c-Jun-N-terminal kinase (JNK) | Nathanael S. Gray | 2016-07-05 |